Corcept Therapeutics Incorporated
CORT
CORT
Nasdaq
Health Technology
Pharmaceuticals: Major
116.28
USD-0.17
-0.15%
Closed: 10-21 20:00 (UTC+0)
116.28
USD+0
+0.00%
Pre-Market: 10-22 12:37 (UTC+0)
CORT Key Statistics
High
118.42
Open
116.45
Volume
516.76K
Low
116.10
Prev. Close
116.45
Trading Value
60.38M
52-Week High
126.38
Relative Volume
1.05
Amplitude (%)
1.99%
52-Week Low
28.66
Turnover Rate
0.48%
Market Cap
12.56B
P/E Ratio (TTM)
277.72
P/E Ratio (Annual)
122.4
P/B Ratio
17.81
P/S Ratio
15.13
Earnings Per Share (EPS)
0.419
Dividend (TTM)
0
Dividend Yield
0.00%
Shares Outstanding
108.09M
Currency Unit
USD
CORT Price Performance
7 day
30 day
90 day
180 day
Year to date
1 Year
CORT Money Flow Distribution
CORT Daily Short Sale Volume
CORT Short Interest History
CORT Stock Snapshot
As of 2026-10-22, the Corcept Therapeutics Incorporated (CORT) stock price today is 116.28. Based on this price, the company has a market capitalization of $12.56B, with a P/E ratio of 277.72.
On 2026-10-22, CORT traded between 116.10 and 118.42. Today’s stock price is 0.16% above the daily low and 1.81% below the daily high, placing CORT near the lower end of its most recent trading range.
Trading volume currently stands at 516.76K, compared with an average daily volume of 492.34K. This suggests that trading activity is roughly in line with its usual level than usual.
Over the past year, Corcept Therapeutics Incorporated shares have traded between 28.66 and 126.38. At today’s price, CORT is 305.72% above its 52-week low and 7.99% below its 52-week high.
CORT Related News
About CORT
Company Name
Corcept Therapeutics Incorporated
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchanges
Nasdaq
Number of Employees
730
Lot Size
100
Official Website
Currency Unit
USD
Corcept Therapeutics Incorporated (CORT) is a commercial-stage pharmaceutical company developing medicines that modulate cortisol activity. It markets Korlym for hypercortisolism and is advancing metabolic, oncology and neuropsychiatric drug candidates.
Related Stocks
CORT FAQ
1.What is the live stock price of Corcept Therapeutics Incorporated (CORT) today?
As of 2026-10-21 20:00 (UTC+0), Corcept Therapeutics Incorporated (CORT) is trading at $116.28, down $0.17 (-0.15%) from the previous trading day’s closing price of $116.45.
3. What were CORT’s trading range and trading volume on the most recent trading day?
On the most recent trading day (2026-10-21 20:00 (UTC+0)), CORT opened at $116.45, reached a high of $118.42, and recorded a low of $116.10. Trading volume for the day was 516.76K, with a total trading value of $60.38M.
The trading volume on that day was 1.05x the average daily volume.
What is the latest after-hours price of CORT?
As of 2026-10-21 20:00 (UTC+0), CORT’s latest after-hours price was $116.28, up $0.00 (+0.00%) from the previous trading day’s close.
7. What are CORT’s 52-week high and 52-week low?
Over the past 52 weeks, CORT has traded between $28.66 and $126.38. Based on the current price, CORT is 305.72% above its 52-week low and 7.99% below its 52-week high.
9. What are CORT’s short sale volume and short interest?
On undefined, CORT had a short sale volume of -- shares, with a short sale ratio of -- and a Nasdaq short sale ratio of --.
As of --, CORT had short interest of -- shares, an average daily trading volume of -- shares, and days to cover.
Short sale volume reflects short-sale transactions on a given day, while short interest reflects short positions that remain open.
11. What are Corcept Therapeutics Incorporated’s P/E ratio and valuation metrics?
As of 2026-10-22 12:44 (UTC+0), Corcept Therapeutics Incorporated has a trailing price-to-earnings ratio, or P/E (TTM), of 277.72, an annual P/E ratio of 122.40, a price-to-book ratio of 17.81, and a price-to-sales ratio of 15.13.
These valuation metrics reflect the relationship between a company’s market price and its earnings, net assets, and revenue. Reasonable valuation levels can vary significantly across companies and industries.
13. What were Corcept Therapeutics Incorporated’s revenue and net income in the most recent quarter?
For the most recent quarter, Corcept Therapeutics Incorporated reported revenue of -- and net income of --. Revenue was -- -- year over year, while net income was -- -- year over year.
15.What is Corcept Therapeutics Incorporated’s total number of shares outstanding?
Corcept Therapeutics Incorporated has 108.10M shares outstanding. Total shares outstanding refers to the total number of shares issued by the company and held by investors.
17. Which exchange is Corcept Therapeutics Incorporated listed on, and what sector and industry does it belong to?
Corcept Therapeutics Incorporated (CORT) is listed on Nasdaq. It belongs to the Health Technology sector and the Pharmaceuticals: Major industry.
Sector and industry classifications can help investors understand the company’s primary business area and compare it with other publicly traded companies in the same industry.
19. What risks should investors consider before investing in CORT?
Before investing in CORT, investors should consider changes in Corcept Therapeutics Incorporated’s revenue and profitability, valuation levels, industry competition, operational risks, the macroeconomic environment, and stock price volatility. Analyst forecasts and technical indicators may change and should not be used as the sole basis for investment decisions.
2.What is the ticker symbol for Corcept Therapeutics Incorporated?
The ticker symbol for Corcept Therapeutics Incorporated is CORT.
4. What is the latest pre-market price of CORT?
As of 2026-10-21 13:20 (UTC+0), CORT’s latest pre-market price was $117.01, up $0.00 (+0.00%) from the previous trading day’s close.
6.How has CORT’s stock price performed recently?
As of 2026-10-22 12:44 (UTC+0), CORT is down NaN% over the past 7 days, down NaN% over the past 30 days, down NaN% year to date, and down NaN% over the past year.
Past price performance reflects historical gains and losses only and is not indicative of future performance.
8. What is the current capital flow for CORT?
As of 2026-10-22 12:44 (UTC+0), CORT recorded a net capital outflow of $NaN. Of this, net large-order inflow was $0, net medium-order inflow was $0, and net small-order outflow was $0.
A positive net capital inflow generally indicates that buying activity exceeded selling activity, while a negative value indicates relatively greater selling activity. Capital flows may continue to change as market trading progresses.
10. What is the current price of NVDA stock perps?
As of 2026-10-22 12:44 (UTC+0), the live price of CORT stock perps is --, with a 24-hour change of --.
Total open interest in CORT stock perps is currently --, with a 24-hour trading volume of -- and an open-interest-weighted funding rate of --.
Stock perps are offered by cryptocurrency trading platforms and are different trading products from shares listed on securities exchanges. Their prices, liquidity and trading hours may differ.
CoinGlass currently provides live prices, funding rates, open interest, trading volume, liquidations, long/short ratios and market data across exchanges for stock perps.
12. What is the market capitalization of Corcept Therapeutics Incorporated?
As of 2026-10-22 12:44 (UTC+0), Corcept Therapeutics Incorporated has a market capitalization of approximately $12.57B. Market capitalization is calculated based on the current stock price and the company’s total shares outstanding and may fluctuate as the stock price changes.
14. What is Corcept Therapeutics Incorporated’s earnings per share (EPS)?
Based on trailing twelve-month data, Corcept Therapeutics Incorporated’s earnings per share, or EPS (TTM), is $0.42. EPS measures the amount of a company’s earnings attributable to each outstanding share of common stock.
16. Does Corcept Therapeutics Incorporated pay dividends?
Corcept Therapeutics Incorporated paid dividends of 0.000 per share over the trailing twelve months. Based on the current stock price, its dividend yield is approximately 0.00%. Future dividend amounts and payment dates may change.
18. How many employees does Corcept Therapeutics Incorporated have?
Based on the latest available company data, Corcept Therapeutics Incorporated had approximately 730 employees as of 2026-10-22. The number of employees may vary due to workforce changes, the reporting date, and differences in disclosure methodology.
1.What is the live stock price of Corcept Therapeutics Incorporated (CORT) today?
As of 2026-10-21 20:00 (UTC+0), Corcept Therapeutics Incorporated (CORT) is trading at $116.28, down $0.17 (-0.15%) from the previous trading day’s closing price of $116.45.
2.What is the ticker symbol for Corcept Therapeutics Incorporated?
The ticker symbol for Corcept Therapeutics Incorporated is CORT.
3. What were CORT’s trading range and trading volume on the most recent trading day?
On the most recent trading day (2026-10-21 20:00 (UTC+0)), CORT opened at $116.45, reached a high of $118.42, and recorded a low of $116.10. Trading volume for the day was 516.76K, with a total trading value of $60.38M.
The trading volume on that day was 1.05x the average daily volume.
4. What is the latest pre-market price of CORT?
As of 2026-10-21 13:20 (UTC+0), CORT’s latest pre-market price was $117.01, up $0.00 (+0.00%) from the previous trading day’s close.
What is the latest after-hours price of CORT?
As of 2026-10-21 20:00 (UTC+0), CORT’s latest after-hours price was $116.28, up $0.00 (+0.00%) from the previous trading day’s close.
6.How has CORT’s stock price performed recently?
As of 2026-10-22 12:44 (UTC+0), CORT is down NaN% over the past 7 days, down NaN% over the past 30 days, down NaN% year to date, and down NaN% over the past year.
Past price performance reflects historical gains and losses only and is not indicative of future performance.
7. What are CORT’s 52-week high and 52-week low?
Over the past 52 weeks, CORT has traded between $28.66 and $126.38. Based on the current price, CORT is 305.72% above its 52-week low and 7.99% below its 52-week high.
8. What is the current capital flow for CORT?
As of 2026-10-22 12:44 (UTC+0), CORT recorded a net capital outflow of $NaN. Of this, net large-order inflow was $0, net medium-order inflow was $0, and net small-order outflow was $0.
A positive net capital inflow generally indicates that buying activity exceeded selling activity, while a negative value indicates relatively greater selling activity. Capital flows may continue to change as market trading progresses.
9. What are CORT’s short sale volume and short interest?
On undefined, CORT had a short sale volume of -- shares, with a short sale ratio of -- and a Nasdaq short sale ratio of --.
As of --, CORT had short interest of -- shares, an average daily trading volume of -- shares, and days to cover.
Short sale volume reflects short-sale transactions on a given day, while short interest reflects short positions that remain open.
10. What is the current price of NVDA stock perps?
As of 2026-10-22 12:44 (UTC+0), the live price of CORT stock perps is --, with a 24-hour change of --.
Total open interest in CORT stock perps is currently --, with a 24-hour trading volume of -- and an open-interest-weighted funding rate of --.
Stock perps are offered by cryptocurrency trading platforms and are different trading products from shares listed on securities exchanges. Their prices, liquidity and trading hours may differ.
CoinGlass currently provides live prices, funding rates, open interest, trading volume, liquidations, long/short ratios and market data across exchanges for stock perps.
11. What are Corcept Therapeutics Incorporated’s P/E ratio and valuation metrics?
As of 2026-10-22 12:44 (UTC+0), Corcept Therapeutics Incorporated has a trailing price-to-earnings ratio, or P/E (TTM), of 277.72, an annual P/E ratio of 122.40, a price-to-book ratio of 17.81, and a price-to-sales ratio of 15.13.
These valuation metrics reflect the relationship between a company’s market price and its earnings, net assets, and revenue. Reasonable valuation levels can vary significantly across companies and industries.
12. What is the market capitalization of Corcept Therapeutics Incorporated?
As of 2026-10-22 12:44 (UTC+0), Corcept Therapeutics Incorporated has a market capitalization of approximately $12.57B. Market capitalization is calculated based on the current stock price and the company’s total shares outstanding and may fluctuate as the stock price changes.
13. What were Corcept Therapeutics Incorporated’s revenue and net income in the most recent quarter?
For the most recent quarter, Corcept Therapeutics Incorporated reported revenue of -- and net income of --. Revenue was -- -- year over year, while net income was -- -- year over year.
14. What is Corcept Therapeutics Incorporated’s earnings per share (EPS)?
Based on trailing twelve-month data, Corcept Therapeutics Incorporated’s earnings per share, or EPS (TTM), is $0.42. EPS measures the amount of a company’s earnings attributable to each outstanding share of common stock.
15.What is Corcept Therapeutics Incorporated’s total number of shares outstanding?
Corcept Therapeutics Incorporated has 108.10M shares outstanding. Total shares outstanding refers to the total number of shares issued by the company and held by investors.
16. Does Corcept Therapeutics Incorporated pay dividends?
Corcept Therapeutics Incorporated paid dividends of 0.000 per share over the trailing twelve months. Based on the current stock price, its dividend yield is approximately 0.00%. Future dividend amounts and payment dates may change.
17. Which exchange is Corcept Therapeutics Incorporated listed on, and what sector and industry does it belong to?
Corcept Therapeutics Incorporated (CORT) is listed on Nasdaq. It belongs to the Health Technology sector and the Pharmaceuticals: Major industry.
Sector and industry classifications can help investors understand the company’s primary business area and compare it with other publicly traded companies in the same industry.
18. How many employees does Corcept Therapeutics Incorporated have?
Based on the latest available company data, Corcept Therapeutics Incorporated had approximately 730 employees as of 2026-10-22. The number of employees may vary due to workforce changes, the reporting date, and differences in disclosure methodology.
19. What risks should investors consider before investing in CORT?
Before investing in CORT, investors should consider changes in Corcept Therapeutics Incorporated’s revenue and profitability, valuation levels, industry competition, operational risks, the macroeconomic environment, and stock price volatility. Analyst forecasts and technical indicators may change and should not be used as the sole basis for investment decisions.
© 2026 CoinGlass, all rights reserved
